Safety concerns about perisurgical epoetin treatment: should we add antiplatelet drugs to perisurgical epoetin alfa treatment?

J Cardiothorac Vasc Anesth. 2007 Aug;21(4):623-4. doi: 10.1053/j.jvca.2006.07.010. Epub 2006 Oct 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia / prevention & control*
  • Epoetin Alfa
  • Erythropoietin / therapeutic use*
  • Female
  • Heart Valve Prosthesis Implantation*
  • Hematinics / therapeutic use*
  • Humans
  • Middle Aged
  • Mitral Valve Stenosis / surgery*
  • Postoperative Complications / prevention & control
  • Preoperative Care / methods*
  • Recombinant Proteins
  • Risk Factors
  • Treatment Outcome

Substances

  • Hematinics
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa